Introduction {#s1}
============

Melatonin, chemically *N*-acetyl-5-methoxytryptamine, is a low-molecular-weight substance found in living organisms ranging from bacteria to animals, with pleiotropic biological activities ([@B16]; [@B17]; [@B45]). In plants, melatonin has a wide range of physiological functions such as regulating plant stress tolerance, senescence retardation, and pathogen defense. Additionally, melatonin also participates in the processes of root growth and architecture, ﬂowering, seed germination, and fruit ripening ([@B1]; [@B2]; [@B59]; [@B39]; [@B28]). Regarding growth regulation, melatonin has been found to promote growth in shoots, roots, and also explants. Melatonin reportedly stimulated root generation and cotyledon expansion, induced new lateral and adventitious roots, and also extended the coleoptiles in some monocot plants ([@B38]; [@B21]; [@B43]; [@B48]; [@B19]; [@B12]). Melatonin also acts as a growth promoter inducing active growth of hypocotyls in etiolated seedlings of lupin at micromolar concentrations while displaying an inhibitory effect at 100 μM ([@B20]). Generally, growth inhibition by melatonin only occurs at a high concentration (\> 100 μM). High-concentration melatonin repressed root growth and reduced biomass, as well as retarded plant leaf growth by reducing both cell size and cell proliferation ([@B55]; [@B36]). Although melatonin plays an important role in the regulation of plant growth and development, the underlying mechanism is still unclear and remains to be elucidated.

In early studies, melatonin was considered primarily as an auxin-like effector in regulating of plant growth. However, to date, the accumulated data suggested that melatonin functions as a new plant hormone or regulator with versatile and complex activities in which it participates in the regulation of gene expression related to plant hormones including auxin, cytokinin, gibberellins (GAs), abscisic acid, ethylene, jasmonic acid, and salicylic acid ([@B3]; [@B4]). Melatonin showed effects on inducing expression of phytohormone-related genes, such as biosynthesis, catabolism, receptors, and transcription factors, and also influencing the endogenous plant hormone levels and their physiological actions. A recent investigation showed that a drop in melatonin by knockdown of the key enzyme gene like the *SNAT2* (serotonin *N*-acetyltransferase 2) and *TDC* (tryptophan decarboxylase), involved in melatonin biosynthesis, resulted in downregulation of the expression of *DWARF4* gene and reduction on endogenous brassinosteroid (BR) levels as well as a semi-dwarf phenotype in rice ([@B24]; [@B32]), implying that there exists a close relationship between melatonin and the BR signaling pathway.

BRs, a class of plant-specific steroid hormones, play vital roles in regulating plant cell growth and morphogenesis, particularly in hypocotyl cell elongation, as the BR biosynthetic mutants, such as *de-etiolated 2* (*det2*), are defective in hypocotyl elongation and shows a dwarf phenotype ([@B35]; [@B14]; [@B8]). In BR signaling, BRs are perceived by the BR receptor BR-insensitive 1 (BRI1), which initiates a signaling cascade to inactivate the negative regulator BR insensitive 2 (BIN2), thereby activating the downstream transcription factors brassinazole-resistant 1 (BZR1) and *bri1*-EMS suppressor 1 (BES1), two key transcription factors mediating BR responses ([@B33]; [@B34]; [@B60]; [@B53]; [@B57]; [@B65]). BZR1 and BES1 play central roles in BR-regulated gene expression and plant development. Activated BZR1 and BES1 accumulate in the nucleus and promote stem elongation through the transcriptional activation of their target genes, such as *PER1*, *IAA19*, *small auxin upregulated RNA* (*SAUR*), and *Expansin A8* (*EXPA8*), involved in cell elongation ([@B51]; [@B62]; [@B6]; [@B57], [@B41]), whereas negatively regulated by feedback suppression of expression of BR-biosynthetic genes like *DWF4*, *CPD*, and *BR6OX2* ([@B37]; [@B5]; [@B58]; [@B15]; [@B18]).

In this study, we found that melatonin inhibited hypocotyl elongation and reprogramed expression of cell elongation genes and BR-biosynthetic genes in a dose-dependent manner in *Arabidopsis*. Through a transcriptome analysis in combination with gene expression analysis, we also found that melatonin inhibited hypocotyl elongation involved in repressing BR pathway. Additionally, we demonstrated that melatonin inhibited BR biosynthesis but did not block BR signaling in the regulation of hypocotyl elongation in *Arabidopsis*. Our findings provide new insights into the function of melatonin in the regulation of plant hormone signaling pathways.

Materials and Methods {#s2}
=====================

Plant Materials and Growth Conditions {#s2_1}
-------------------------------------

The wild-type (WT) *Arabidopsis* Columbia (Col-0) ecotype was used unless otherwise indicated. The mutants used in this study include BR-related mutants *det2-1* ([@B7]), *bri1-5* ([@B40]), *bin2-1* ([@B44]), *bzr1-1D* ([@B58]), and *bes1-D* ([@B61]), in which *bri1-5 and bes1-D* are in Wassilewskija (Ws) and Ertkheim-2 (En2) backgrounds, respectively, and the others are in Col-0 background. Seeds were surface sterilized with 70% (v/v) ethanol for 2 min, followed by 10% (v/v) bleach solution for 5 min, and rinsed with sterile water five times. The seeds were then placed on 1/2 strength Murashige and Skoog (MS) medium (pH = 5.8) containing 1% sucrose and 0.8% agar. Seeds on medium were grown in growth chambers with 22°C and 16-h/8-h light/dark cycle settings unless indicated otherwise.

Hormone or Inhibitor Treatments and Hypocotyl Elongation Assays {#s2_2}
---------------------------------------------------------------

As for the observation of hypocotyl experiments, seeds were incubated 1/2MS medium with various concentrations of melatonin (MEL; Sigma, M5250) or 0.1% dimethyl sulfoxide (DMSO; solvent control) for 7 days or more in the light conditions. For another treatment, 4-day-old seedlings were transferred on medium plates supplemented with melatonin, brassinazole (BRZ; Sigma, SML1406) dissolved in DMSO, brassinolide (BL; Sigma, B1439), indole acetic acid (IAA; Sigma, I5148), gibberellin (GA~3~, Sigma, G7645), or the combination for treatment in darkness for another 3 days. BL, IAA, and GA~3~ were dissolved in 80% ethanol. After the indicated time of incubation, about 40 seedlings were laid horizontally on an agar plate and photographed. Hypocotyl length was measured using the ImageJ software (<http://imagej.nih.gov/ij/>) from digitally computed images of seedlings.

RNA-Seq Analysis {#s2_3}
----------------

RNA-Sequencing was carried out by BGI Life Tech Co. Ltd. (Wuhan, China). Four-day-old seedlings were transferred on 1/2MS plate containing 1 mM of melatonin or 0.1% DMSO (control). After 3 days of incubation in a dark condition, about 100 seedlings were collected as one replicate, and a total of three replicates were used for each treatment. Total RNA was isolated using RNeasy Plant Mini Kit (Tiangen, China) following the manufacturer's protocol. The cDNA libraries were constructed, and the library quality was determined by using Bioanalyzer 2100 (Agilent), subsequently sequenced using the BGISEQ-500 platform (BGI). Clean reads obtained from the raw reads were obtained by removing the adapter and low-quality sequences and then mapped to the annotated genome sequence of *Arabidopsis* in The Arabidopsis Information Resource (TAIR) database (<https://www.arabidopsis.org/>) by using HISAT and Bowtie2 software ([@B31]; [@B29]). Transcript abundance was also normalized by transforming the data to reads per kilobase of exon model per million mapped reads (FPKM) method, and DEGseq method was used to identify differentially expressed genes (DEGs) ([@B54]). A twofold difference in expression levels with an adjusted *p*-value ≤ 0.001 (*q*-value ≤ 0.001) was set as the threshold for the determination of the significant changes ([@B50]). Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were carried out with the web tool DAVID bioinformatics resources 6.8 (<http://david.abcc.ncifcrf.gov/home.jsp>) ([@B22]; [@B23]) and KOBAS (<http://kobas.cbi.pku.edu.cn/home.do>) ([@B27]; [@B26]). All RNA-Seq data are available in [**Supplementary Table S1**](#SM1){ref-type="supplementary-material"}.

Comparative Analysis of RNA-Seq Data {#s2_4}
------------------------------------

RNA-Seq was compared with the public online data from published articles. DEGs with 1.5-fold difference were set to keep the consistence between the data. Venn diagrams for expression differences were generated online (<http://bioinfogp.cnb.csic.es/tools/venny/>). Expression levels of overlapping DEGs were exhibited by heatmaps created by using the MeV4.9.0 software ([@B47]). The overlapping DEGs are listed in [**Supplementary Table S2--S3**](#SM1){ref-type="supplementary-material"}.

RNA Isolation and Real-Time PCR (qRT-PCR) Analysis {#s2_5}
--------------------------------------------------

Total RNA was isolated by using the RNAprep Pure Plant Kit (TianGen, DP432), and reverse transcription was performed using the PrimeScript™ RT Reagent Kit (Takara, RR047A) following the manufacturer's instructions. Real-time polymerase chain reaction (qRT-PCR) was performed on a Bio-Rad CFX96 System (Bio-Rad) using the TB Green™ Premix Ex Taq™ (Takara, RR420A). *ACTIN2* was used as internal control for BR-related experiments. Primer sequences used for qRT-PCR analyses are listed in [**Supplementary Table S4**](#SM1){ref-type="supplementary-material"}.

Bioactive BRs Determination by ELISA {#s2_6}
------------------------------------

Ten-day-old seedlings grown on 1/2MS, including various concentrations of melatonin (100, 500, and 1,000 μM), 1 μM of BRZ, or 0.1% DMSO (control), were collected for determining BR levels. Bioactive BR contents were quantified by enzyme-linked immunosorbent assay (ELISA) as described previously ([@B24]).

Data Processing {#s2_7}
---------------

The presented results were obtained from three independent experiments. Data were expressed as means ± standard deviations (SDs) of 40 plants (*n* ≥ 40) with each measurement performed in triplicate. The data were evaluated by a one-way analysis of variance (ANOVA), followed by Student tests at a signiﬁcance level of *p* \< 0.05 (\*) or extremely significant level of *p* \< 0.01 (\*\*).

Accession Numbers {#s2_8}
-----------------

Information for the main genes involving in this study is available in The TAIR (<http://www.arabidopsis.org/>) under the following accession numbers: *Paclobutrazol resistance1* (*PRE1*) (AT5G39860), *IAA19* (AT3G15540), *ACS5* (AT5G65800), *SAUR15* (AT4G38850), *SAUR16* (AT4G38860), *EXPA8* (AT2G40610), *DWF4* (AT3G50660), *CPD* (AT5G05690), *BR6OX2* (AT3G30180), and *ACTIN2* (AT3G18780).

Results {#s3}
=======

Melatonin Inhibits Hypocotyl Elongation of *Arabidopsis* {#s3_1}
--------------------------------------------------------

Melatonin as a plant growth regulator promotes or inhibits plant growth depending on the concentration of melatonin. To understand how melatonin affects plant growth, a series of concentrations of melatonin (0, 1, 10, 100, 500, and 1,000 μM) were set to assess its effects on seedling growth. After 10 days of germination, coincident with previous report, seedlings grown on 1/2MS plates with high-dose melatonin showed obvious growth arrest with smaller cotyledon and true leaves compared with those in solvent control ([**Supplementary Figure S1A**](#SM1){ref-type="supplementary-material"}). Melatonin reportedly promotes hypocotyl growth in etiolated lupin (*Lupinus albus*) at a micromolar concentration level, while it has an inhibitory effect at high concentrations ([@B20]). Similarly, our observation showed that the *Arabidopsis* seedlings also displayed a repressed hypocotyl and cell length by high-dose melatonin in a dose-dependent manner ([**Supplementary Figures S1B, C**](#SM1){ref-type="supplementary-material"}). Specifically, seedlings had displayed slight response to low-dose melatonin (1 and 10 μM); however, when concentrations of melatonin were increased (100, 500, and 1,000 μM), seedlings showed considerable reduction in hypocotyl length, which declined to about 80%, 60%, and 40%, respectively, compared with that of solvent control ([**Supplementary Figure S1D**](#SM1){ref-type="supplementary-material"}). To extend these findings and confirm inhibition in cell elongation of high dose of melatonin, we transferred 4 days seedlings to 1/2MS plates with various concentrations of melatonin (100, 500, and 1,000 μM) and incubation in a dark condition to better observe cell elongation. After 3 days of incubation, similar results were observed in which seedlings showed obvious reduction in hypocotyl and cell length as with increasing dose of melatonin in comparison with solvent control ([**Figures 1A--C**](#f1){ref-type="fig"}).

![RNA-Seq of analysis genes affected by melatonin. Seedlings of four DAGs were transferred on 1/2MS plate containing different concentrations of melatonin (100, 500, and 1,000 µM) or 0.1% DMSO (solvent control). After 3 days of incubation in a dark condition, seedlings from 1 mM of melatonin and DMSO treatment were used for gene expression profile analysis by RNA-Seq. **(A,** **B)** Melatonin inhibits hypocotyl and cell elongation in a dose-dependent manner. **(C)** Hypocotyl length of seedlings. Error bars indicate the SEM (*n* ≥ 40). \**p* \< 0.05, \*\**p* \< 0.01 (Student's *t* test). **(D)** DEGs affected by 1 mM of melatonin. **(E)** The top 30 of the most enriched GO terms (*q*-value \< 0.01). DAG, days after germination; DMSO, dimethyl sulfoxide; GO, gene ontology; MS, Murashige and Skoog; SEM, standard error of the mean.](fpls-10-01082-g001){#f1}

Melatonin Reprograms Cell Elongation Gene Expression {#s3_2}
----------------------------------------------------

To investigate the mechanism of hypocotyl elongation inhibition caused by melatonin, we performed a whole-genome expression profiling analysis between melatonin and DMSO treatment (DMSO as the solvent) by RNA sequencing. RNA-Seq results showed that there were 1,615 DEGs (7.47% of all unigenes), consisting of 776 upregulated DEGs and 839 downregulated DEGs ([**Figure 1D**](#f1){ref-type="fig"}, [**Supplementary Table S1**](#SM1){ref-type="supplementary-material"}). The GO enrichment analysis showed that the DEGs were categorized into 68 significantly (*q*-value \< 0.01) enriched GO terms including 17 terms of cellular component in which typical terms in respect to cell elongation, such as "cell wall" and "plant-type cell wall," were included ([**Supplementary Table S5**](#SM1){ref-type="supplementary-material"}). In the top 30 of the most enriched GO terms, there were 11 terms involved in cellular component ([**Figure 1E**](#f1){ref-type="fig"}). As far as the number of genes are concerned, many DEGs were enriched in cellular component ontology following the terms of "membrane part (504)," "intrinsic components of membrane (497)," and "integral component of membrane (466)," etc. ([**Figure 1E**](#f1){ref-type="fig"}). Furthermore, the KEGG pathway analysis showed that the majority of DEGs were mainly distributed on 26 significantly enriched KEGG pathways (*q*-value \< 0.05), such as "Phenylpropanoid biosynthesis," "Biosynthesis of secondary metabolites," and "Metabolic pathways" ([**Figure 2A**](#f2){ref-type="fig"}, [**Supplementary Table S6**](#SM1){ref-type="supplementary-material"}). In addition, we found that "brassinosteroid biosynthesis" pathway displayed in the top 20 of most significantly enriched KEGG pathways ([**Figure 2A**](#f2){ref-type="fig"}), and BR biosynthesis-related genes, such as three cytochrome P450 superfamily genes (*CYP724A1*, *CYP90D1*, and *BR6OX2*) and one abietane diterpene oxidase gene *ADTO1* ([@B15]), showed differential expression ([**Figure 2B**](#f2){ref-type="fig"}, [**Table 1**](#T1){ref-type="table"}), suggesting that melatonin affects the BR metabolism.

![KEGG analysis of DEGs affected by melatonin. **(A)** The top 20 of the most significantly enriched KEGG pathways (*q*-value \< 0.05). **(B)** Expression changes of genes in the brassinosteroid biosynthesis pathway. Red boxes, upregulated genes; green boxes, downregulated genes. KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes.](fpls-10-01082-g002){#f2}

###### 

Differentially expressed genes involved in brassinosteroid biosynthesis and cell elongation.

  Gene ID                            Symbol                                                                Log2FC   *q*-value
  ---------------------------------- --------------------------------------------------------------------- -------- -----------
  **Brassinosteroid biosynthesis**                                                                                  
  AT3G13730                          Cytochrome P450, family 90, subfamily D, polypeptide 1 (CYP90D1)      1.02     0.000000
  AT3G30180                          Brassinosteroid-6-oxidase 2 (BR6OX2)                                  1.66     0.000000
  AT5G14400                          Cytochrome P450, family 724, subfamily A, polypeptide 1 (CYP724A1)    −4.58    0.000431
  AT1G73340                          Abietane diterpene oxidase 1 (ADTO1)                                  −1.01    0.000023
  **Cell elongation/expansion**                                                                                     
  AT5G39860                          Paclobutrazol resistance1 (PRE1)                                      −1.30    0.000000
  AT3G15540                          Indole-3-acetic acid inducible 19 (IAA19)                             −1.61    0.000000
  AT1G52830                          Indole-3-acetic acid inducible 6 (IAA6)                               −1.55    0.000001
  AT1G15050                          Indole-3-acetic acid inducible 34 (IAA34)                             −1.95    0.000000
  AT2G01200                          Indole-3-acetic acid inducible 32 (IAA32)                             −1.04    0.000000
  AT4G34790                          Small auxin upregulated RNA 3 (SAUR3)                                 −1.42    0.000000
  AT2G21200                          Small auxin upregulated RNA 7 (SAUR7)                                 −1.13    0.000005
  AT4G36110                          Small auxin upregulated RNA 9 (SAUR9)                                 −1.46    0.000000
  AT4G38825                          Small auxin upregulated RNA 13 (SAUR13)                               −1.81    0.000000
  AT5G18010                          Small auxin upregulated RNA 19 (SAUR19)                               −1.62    0.000000
  AT5G18020                          Small auxin upregulated RNA 20 (SAUR20)                               −1.23    0.000000
  AT5G18030                          Small auxin upregulated RNA 21 (SAUR21)                               −1.07    0.000000
  AT5G18050                          Small auxin upregulated RNA 22 (SAUR22)                               −1.84    0.000000
  AT5G18060                          Small auxin upregulated RNA 23 (SAUR23)                               −1.30    0.000000
  AT5G18080                          Small auxin upregulated RNA 24 (SAUR24)                               −1.25    0.000000
  AT4G13790                          Small auxin upregulated RNA 25 (SAUR25)                               −2.36    0.000000
  AT3G03820                          Small auxin upregulated RNA 29 (SAUR29)                               −1.40    0.000000
  AT4G22620                          Small auxin upregulated RNA 34 (SAUR34)                               −1.34    0.000321
  AT2G28085                          Small auxin upregulated RNA 42 (SAUR42)                               −2.11    0.000254
  AT1G79130                          Small auxin upregulated RNA 40 (SAUR40)                               −1.65    0.000061
  AT1G29430                          Small auxin upregulated RNA 62 (SAUR62)                               −1.38    0.000000
  AT1G29440                          Small auxin upregulated RNA 63 (SAUR63)                               −1.29    0.000000
  AT1G29460                          Small auxin upregulated RNA 65 (SAUR65)                               −1.34    0.000000
  AT5G20820                          Small auxin upregulated RNA 76 (SAUR76)                               −1.06    0.000000
  AT4G13390                          Extensin 12 (EXT12)                                                   1.01     0.000000
  AT1G21310                          Extensin (EXT3)                                                       −1.48    0.000000
  AT2G43150                          Proline-rich extensin-like family protein                             −1.74    0.000000
  AT3G28550                          Proline-rich extensin-like family protein                             −1.34    0.000000
  AT3G24480                          Proline-rich extensin-like family protein                             −1.24    0.000000
  AT1G65310                          Xyloglucan endotransglucosylase/hydrolase 17 (XTH17)                  −1.17    0.000000
  AT3G23730                          Xyloglucan endotransglucosylase/hydrolase 16 (XTH16)                  −1.01    0.000000
  AT4G25810                          Xyloglucan endotransglycosylase 6 (XTR6)                              1.04     0.000000
  AT4G28850                          Xyloglucan endotransglucosylase/hydrolase 26 (XTH26)                  1.19     0.000000
  AT3G48580                          Xyloglucan endotransglucosylase/hydrolase 11 (XTH11)                  1.47     0.000000
  AT1G70720                          Plant invertase/pectin methylesterase inhibitor superfamily protein   −2.52    0.000000
  AT2G45220                          Pectin methylesterase 17 (ATPME17)                                    −2.05    0.000000
  AT3G26610                          Polygalacturonase involved in expansion 1 (PGX1)                      −1.17    0.000000
  AT5G55590                          Quartet1 (QRT1)                                                       2.38     0.000000
  AT2G21610                          Pectinesterase 11 (PE11)                                              1.67     0.000290
  AT5G20860                          Plant invertase/pectin methylesterase inhibitor superfamily           2.18     0.000000
  AT3G12880                          Plant invertase/pectin methylesterase inhibitor superfamily protein   2.55     0.000003
  AT2G14900                          Gibberellin-regulated family protein                                  −1.07    0.000000
  AT5G14920                          GA-stimulated in *Arabidopsis* 14 (GASA14)                            −1.06    0.000000
  AT1G22690                          Gibberellin-regulated family protein                                  1.40     0.000000
  AT4G23560                          Glycosyl hydrolase 9B15 (GH9B15)                                      −2.82    0.000089
  AT4G02290                          Glycosyl hydrolase 9B13 (GH9B13)                                      −1.16    0.000000
  AT2G32990                          Glycosyl hydrolase 9B8 (GH9B8)                                        1.37     0.000000
  AT1G24070                          Cellulose synthase-like A10 (CSLA10)                                  −1.47    0.000003
  AT4G24000                          Cellulose synthase-like G2 (CSLG2)                                    1.73     0.000000
  AT4G38080                          Hydroxyproline-rich glycoprotein family protein                       2.50     0.000000
  AT2G36970                          UDP-glycosyltransferase superfamily protein                           1.61     0.000000

Differentially expressed genes were defined by two-fold change difference between melatonin and dimethyl sulfoxide treatment with q-value ≤ 0.001 ([@B50]).

A further analysis showed that there were 52 DEGs in respect to cell elongation/expansion. Among these DEGs, most of them (38 out of 51) were downregulated and only 13 DEGs were upregulated ([**Table 1**](#T1){ref-type="table"}). In addition, *SAUR* genes involved in auxin response and functions on the regulation of cell elongation and cell expansion ([@B30]; [@B25]; [@B46]) accounted for 37% (19 out of 51) and displayed consistent downregulated expression ([**Table 1**](#T1){ref-type="table"}). In these *SAUR*s, most of them, such as *SAUR15*, *SAUR16*, and *SAUR19* to *SAUR24*, have also been proven to respond to BR signaling in the regulation of hypocotyl growth ([@B13]). Furthermore, the BR-induced genes as well the marker genes like the *PRE1* and *indole-3-acetic acid inducible 19* (*IAA1*9) also displayed decreasing transcript levels ([**Table 1**](#T1){ref-type="table"}). These results suggest that a high concentration of melatonin represses hypocotyl elongation in relation to reprograming cell elongation/expansion genes expression likely through regulating BR metabolism.

Melatonin Regulates BR-Related Genes Expression {#s3_3}
-----------------------------------------------

To investigate the regulatory relationship between melatonin and BR signaling, we screened the BR biosynthesis-related genes and representative BR-induced genes involved in cell elongation in the total detected genes of RNA-Seq data. Except of *CYP724A1*, *CYP90D1*, *BR6OX2*, and *ADTO1*, the key rate-limiting enzyme gene *CPD* in BR biosynthesis also displayed differential upregulated expression at 1.5-fold change threshold ([**Supplementary Table S1**](#SM1){ref-type="supplementary-material"}). Conversely, in addition to *PER1* and *IAA19*, BRs-induced as well as marker genes regulating cell elongation, like the *SAUR15*, *SAUR16*, and *EXPA8*, exhibited consistent downregulated expression with a 1.5-fold change threshold. Furthermore, *ACS5*, usually taken as a marker gene in response to BRs, exhibited reduced transcript level as well ([**Table 1**](#T1){ref-type="table"}, [**Supplementary Table S1**](#SM1){ref-type="supplementary-material"}). We next performed qRT-PCR to validate the expression levels of these BR-biosynthetic and BR-induced genes in the seedlings after being treated with various concentrations of melatonin. Except of the two genes *CYP724A1* and *ADTO1*, which showed smooth expression levels, a consistent trend of expression was obtained with these detected genes ([**Figure 3A**](#f3){ref-type="fig"}). BR-biosynthetic genes (*DWF4*, *CPD*, *CYP90D1*, and *BR6OX2*) showed dramatic enhancement with increasing concentrations of melatonin, especially those of *DWF4* and *BR6OX2* ([**Figure 3A**](#f3){ref-type="fig"})*.* On the contrary, the BR-induced genes (*PER1*, *IAA19*, *ACS5*, *SAUR15*, *SAUR16*, and *EXPA8*) displayed an identical decline in transcript level caused by increasing dose of melatonin ([**Figure 3B**](#f3){ref-type="fig"}). Additionally, we also detected the transcript levels of BZR1 and BES1, two key transcription factors in BR signaling, which promote cell elongation through transcriptional activation of BR-induced genes, such as *PER1*, *IAA19*, *SAUR*s, and *EXPA8*, whereas promote feedback suppression in the expression of BR-biosynthetic genes (like the *DWF4*, *CPD*, and *BR6OX2*) ([@B51]; [@B62]; [@B6]; [@B57]; [@B41]). Consistent with BR-induced genes, *BZR1* and *BES1* also showed downregulated trend in transcript levels with increasing dose of melatonin ([**Figure 3C**](#f3){ref-type="fig"}). These results are consistent with the gene expression of the inhibition of BR signaling, implying that a high dose of melatonin represses BR signaling pathway in the regulation of hypocotyl elongation.

![qRT-PCR analysis of BR-related gene expression under melatonin treatment. Seedlings were grown in light for 4 days and then transferred to 1/2MS plates with various concentrations of melatonin in a dark condition for another 3 days. Expression levels were normalized to an internal control *ACTIN2*. **(A)** qRT-PCR analysis of BR-biosynthetic genes. **(B)** qRT-PCR analysis of BR-induced genes involved in cell elongation. **(C)** qRT-PCR analysis of the two key transcription factors, *BZR1* and *BES1*. Data are represented as means ± SD (*n* = 3), \**p* \< 0.05, \*\**p* \< 0.01 (Student's *t* test). BR, brassinosteroid; MS, Murashige and Skoog; qRT-PCR, real-time polymerase chain reaction.](fpls-10-01082-g003){#f3}

Melatonin Inhibits Hypocotyl Elongation by Repressing BR Signaling {#s3_4}
------------------------------------------------------------------

Based on the above observations, we speculated that melatonin inhibits hypocotyl likely by direct repression of BR signaling. This idea was supported by the melatonin sensitivity experiment performed on *bzr1-1D* and *bes1-D*, which are BR constitutive active form mutants of *BZR1* and *BES1*, respectively. Similar with the BR biosynthetic inhibitor BRZ, melatonin markedly (*p* \< 0.01) inhibited hypocotyl elongation of WT but showed slight (*p* \< 0.05) suppression on *bzr1-1D* and had no impact on hypocotyl elongation of *bes1-D* ([**Figures 4A, B**](#f4){ref-type="fig"}). Furthermore, an expression analysis also showed the same tendency in downregulation of BR-induced genes (*PRE1*, *IAA19*, *ACS5*, *EXP8*, *SAUR15*, and *SUAR16*) between melatonin and BRZ ([**Figure 4C**](#f4){ref-type="fig"}), suggesting that high concentrations of melatonin are equivalent to the BRZ in the inhibition of hypocotyl elongation. We also analyzed the expression of these genes in *bzr1-1D* seedlings after being treated with melatonin and found that these genes were poorly affected by melatonin as compared to those of WT control ([**Figure 4D**](#f4){ref-type="fig"}). In addition, the upregulation of *DWF4* and *BR6OX2* caused by melatonin was partly suppressed in *bzr1-1D* ([**Figure 4E**](#f4){ref-type="fig"}).

![High-dose melatonin represses BR signaling. **(A, B)** Four-day-old seedlings of WT, *bzr1-1D*, and *bes1-D* were transferred on medium containing 1 mM of melatonin (MEL), 1 µM brassinazole (BRZ), or 0.1% DMSO (solvent control) for 3 days in darkness. Scale bar represents 0.5 cm. \**p* \< 0.05, \*\**p* \< 0.01 (Student's *t* test). Error bars indicate the SEM (*n* ≥ 40). **(C)** qRT-PCR analyses of expression of BR-related genes in WT seedlings under treatment of MEL, BRZ, and DMSO (control). Data are represented as means ± SD (*n* = 3), \**p* \< 0.05, \*\**p* \< 0.01 (Student's *t* test). **(D, E)** Expression level analysis of BR-related genes in both WT and *bzr1-1D* after being treated with melatonin. Significant differences (*p* \< 0.05) are denoted by different lowercase letters. **(F)** Venn diagram displaying the overlapping genes regulated by melatonin and BZR1. **(G, H)** Hierarchical cluster analysis of 990 overlapping genes and the representative genes in BR signaling are listed. Red and green colors in the heatmap represent induced and repressed genes, respectively. BR, brassinosteroid; DMSO, dimethyl sulfoxide; qRT-PCR, real-time polymerase chain reaction; SEM, standard error of the mean; WT, wild type.](fpls-10-01082-g004){#f4}

We then carried out a comparative transcription analysis between the data of MEL versus DMSO and that of *bzr1-1D* versus Col, which was obtained from public RNA-Seq data online ([**Supplementary Table S2**](#SM1){ref-type="supplementary-material"}) ([@B52]). We found that of 3,272 DEGs regulated by melatonin, 990 genes (30%) were shared by the DEGs (4,428) in *bzr1-D* versus Col group ([**Figure 4F**](#f4){ref-type="fig"}). Heatmap showed an opposite pattern of expression among these overlapping genes, in which 705 genes (71%) were affected in the opposite way ([**Figure 4G**](#f4){ref-type="fig"}). In particular, the marker genes of BR signaling, such as BR-biosynthetic genes (*BR6OX2* and *CPD*) and BR-induced gens (*PER1*, *IAA19*, *EXPA8*, *SAUR*s, etc) involved in cell elongation, also displayed an opposite expression trend ([**Figure 4H**](#f4){ref-type="fig"}), suggesting that the inhibition of hypocotyl elongation caused by melatonin involves the repression of BR signaling.

BL Antagonizes Melatonin in the Regulation of Hypocotyl Elongation {#s3_5}
------------------------------------------------------------------

Exogenous BL is usually used to rescue dwarf hypocotyl of BR biosynthesis synthesis mutants ([@B58]; [@B9]). To test the relationship between the melatonin and BR pathways, we transferred the seedlings to melatonin-enriched medium supplemented with various concentrations of BL. The results showed that hypocotyl inhibition caused by high dose of melatonin was gradually restored by additional BL, but not IAA or GA~3~ ([**Figures 5A, B**](#f5){ref-type="fig"}, and [**Supplementary Figure S2**](#SM1){ref-type="supplementary-material"}). Consistent with the retrieval of *bzr1-1D* and *bes1-D* on hypocotyl repression caused by melatonin ([**Figure 4A**](#f4){ref-type="fig"}), the inhibitory effects of 1 mM of melatonin on hypocotyl were almost eliminated by 1 μM BL ([**Figures 5A, B**](#f5){ref-type="fig"}). Furthermore, an expression analysis of BR-related genes showed that BL antagonized the high dose of melatonin in the regulation of the expression of BR-related genes. Concretely, BL increased the expression of BR-induced genes (*PRE1*, *IAA19*, *ACS5*, *SAUR15*, and *SUAR16*) but reduced the expression of BR-biosynthetic genes (*DAWF4*, *CPD*, and *BR6OX2*), even in the presence of 1 mM of melatonin ([**Figure 5C**](#f5){ref-type="fig"}), implying that melatonin affects BR biosynthesis.

![BL antagonizes melatonin in the regulation of hypocotyl elongation. **(A)** Additional BL restores hypocotyl elongation against a high concentration of melatonin. Four-day-old seedlings grown on 1/2MS under light were transferred on medium containing 1 mM of melatonin with indicated concentration of BL for another 3 days in darkness. Scale bar represents 0.5 cm. **(B)** The corresponding hypocotyl length.\**p* \< 0.05, \*\**p* \< 0.01 (Student's *t* test). Error bars indicate the SEM (*n* ≥ 40). **(C)** qRT-PCR analyses showing the expression of BR-related genes. Significant differences (*p* \< 0.05) are denoted by different lowercase letters. **(D)** Venn diagram displaying the overlapping genes induced by melatonin and BL. **(E, F)** Hierarchical cluster analysis of 775 overlapping genes and the representative genes in BR signaling are listed. Red and green colors in the heatmap represent induced and repressed genes, respectively. BL, brassinolide; MS, Murashige and Skoog; qRT-PCR, real-time polymerase chain reaction; SEM, standard error of the mean.](fpls-10-01082-g005){#f5}

To further explore the regulatory relationship between melatonin and BR signaling, we compared the 3,272 DEGs (1.5-fold change) affected by melatonin (MEL versus DMSO) with the 2,664 DEGs induced by BL (BL versus mock) from public RNA-Seq data ([**Supplemental Table S3**](#SM1){ref-type="supplementary-material"}) ([@B42]) and found that of 3,272 melatonin regulated DEGs, and 775 genes (24%) were also affected by BL ([**Figure 5D**](#f5){ref-type="fig"}, [**Supplementary Table S3**](#SM1){ref-type="supplementary-material"}). Among these co-regulated genes, 544 genes (70%) in MEL versus DMSO group were downregulated, whereas in BL versus mock group, most of the genes (492 out of 775) were upregulated ([**Supplementary Table S3**](#SM1){ref-type="supplementary-material"}). Heatmap also showed an opposite regulated mode where 597 (77%) genes were affected in an opposite way between melatonin and BL ([**Figure 5E**](#f5){ref-type="fig"}, [**Supplementary Table S3**](#SM1){ref-type="supplementary-material"}). In addition, some representative genes such as BR-biosynthetic genes (*CYP90D1*, *BR6OX2*, and *CPD*) and BR-induced genes (*PER1*, *IAA19*, *ACS5*, *EXPA8*, *SAUR15*, *SAUR16*, etc.) of the co-regulated genes exhibited reverse expression mode ([**Figure 5F**](#f5){ref-type="fig"}). In addition, similar results were observed when genes affected by melatonin (MEL versus DMSO) were compared with the genes induced by BL (BL versus mock) and the genes regulated in *bzr1-1D* (*bzr1-1D* versus Col) ([**Supplementary Figure S3**](#SM1){ref-type="supplementary-material"}).

Melatonin Inhibits BR Biosynthesis {#s3_6}
----------------------------------

To explore how melatonin acts on BR signaling, the effects of melatonin on BR-deﬁcient mutants were also investigated, such as BR synthesis mutant *det2-1*, the BR receptor mutant *bir1-5*, and BR-insensitive 2 mutant *bin 2-1.* The results showed that exogenous melatonin had little effect on hypocotyl elongation of these BR-deﬁcient mutants compared with the control whether they were under normal light or dark conditions ([**Figure 6A**](#f6){ref-type="fig"})*.* It has been report that additional BL can repress a BR-deﬁcient phenotype of BR synthesis mutants (such as *det2*, *cpd*, and *dwarf4*), but not to BR receptor mutants or other mutants involved in BR signal transduction ([@B58]; [@B9]). Consistent with previous reports, exogenous BL dramatically promoted hypocotyl elongation of *det2-1* but not *bri1-5* and *bin2-1*, even in presence of a high dose of melatonin ([**Figures 6A--C**](#f6){ref-type="fig"}). Furthermore, we measured the bioactive BR contents by ELISA method. Consistent with the hypocotyl inhibition, a high concentration of melatonin reduced endogenous BR levels to a similar extent with biosynthetic inhibitor BRZ ([**Figures 7A--C**](#f7){ref-type="fig"}). These results further confirmed that a high dose of melatonin repressed BR biosynthesis in the inhibition of hypocotyl elongation.

![Melatonin involves in repressing BR biosynthesis. **(A)** Phenotype of BR-related mutants like the *det2-1*, *bri1-5*, and *bin2-1* response to 1 mM of melatonin, 1 µM of BL or their combination, and mock solvent as the control. Scale bar represents 0.5 cm. **(B, C)** Hypocotyl length of the corresponding seedlings. Error bars indicate the SEM (*n* ≥ 40). Significant differences (*p* \< 0.05) are denoted by different lowercase letters. BL, brassinolide; BR, brassinosteroid; SEM, standard error of the mean.](fpls-10-01082-g006){#f6}

![Melatonin reduces endogenous BR levels. Seedlings 12 DAG from 1/2MS amended with melatonin, BRZ, or DMSO (control) were collected for the determination of BR levels by ELISA method. **(A)** Phenotype of seedlings from melatonin, BRZ, or DMSO treatments. **(B)** Hypocotyl length of the corresponding seedlings. \**p* \< 0.05, \*\**p* \< 0.01 (Student's *t* test). Error bars indicate the SEM (*n* ≥ 40). **(C)** Endogenous bioactive BR content. Data are represented as means ± SD (*n* = 3), \**p* \< 0.05 (Student's *t* test). BR, brassinosteroid; BRZ, brassinazole; DAG, days after germination; DMSO, dimethyl sulfoxide; ELISA, enzyme-linked immunosorbent assay; MS, Murashige and Skoog; SEM, standard error of the mean.](fpls-10-01082-g007){#f7}

Discussion {#s4}
==========

Melatonin functions as a pleiotropic regulator in the regulation of plant growth, development, and multiple stress responses ([@B17]; [@B1]; [@B2]; [@B11]; [@B39]; [@B28]). In terms of dosage melatonin, the working concentration of melatonin is usually considerably higher than that of other plant hormones in the study of plant growth and development. For example, in the research of how melatonin regulates *Arabidopsis* root system architecture, the maximum concentration of melatonin (600 μM) was used ([@B43]); in another study, melatonin regulates the floral transition in *Arabidopsis*, and up to 1 mM of melatonin was applied ([@B49]). In addition, a high concentration of melatonin (1 mM) was used to investigate its inhibitory effects on leaf development in *Arabidopsis* ([@B55]). Growth retardations caused by a relatively high concentration of exogenous melatonin have been reported in many studies. It has been reported that melatonin at a high concentration shows an inhibitory effect on hypocotyl elongation of etiolated seedlings in lupin ([@B20]). A recent study showed us that high-concentration melatonin restrained root growth and reduced biomass, as well as retarded plant leaf growth by reducing both cell size and cell proliferation ([@B55]; [@B36]). There were many investigations showing that high-dose melatonin accompanied inhibitory effects; however, the molecular mechanism remains largely unknown. In present study, we found that a high dose of melatonin inhibited hypocotyl and cell elongation ([**Supplementary Figure S1**](#SM1){ref-type="supplementary-material"}, [**Figures 1A--C**](#f1){ref-type="fig"}) and mechanistically revealed that hypocotyl inhibition of melatonin is involved in the repression of BR biosynthesis in *Arabidopsis*.

Our data revealed that there were 1,615 DEGs affected by melatonin, in which many genes involved in cell elongation/expansion were downregulated ([**Figure 1D**](#f1){ref-type="fig"}, [**Table 1**](#T1){ref-type="table"}, [**Supplementary Table S1**](#SM1){ref-type="supplementary-material"}). This also explains why a high dose of melatonin inhibits hypocotyl elongation. There are several literatures described that melatonin participates in regulating gene expression in respect with plant hormones including auxin, cytokinin, GAs, abscisic acid, ethylene, jasmonic acid, and salicylic acid ([@B3]; [@B4]). Melatonin showed effects on inducing expression of phytohormone related-genes such as biosynthesis, catabolism, receptors, and transcription factors ([@B3]; [@B4]). Our KEGG pathway analysis also found that "brassinosteroid biosynthesis" pathway listed in the top 20 of most significantly enriched KEGG pathways and BR biosynthesis-related genes showed differential expression ([**Figures 2A, B**](#f2){ref-type="fig"}, [**Table 1**](#T1){ref-type="table"}), suggesting that melatonin affects the BR metabolism. It is well known that BRs play a predominant role in the regulation of cell elongation; thus, we speculated that hypocotyl inhibition of melatonin is likely to be involved in the regulation of BR signaling. Our results further showed that melatonin modulated BR-related genes expression, such as downregulating BR-induced genes involved in cell elongation (*PRE1*, *IAA19*, and *SAUR*s) but upregulating BR-biosynthetic genes (*DAWF4*, *CPD*, and *BR6OX2*) ([**Figures 3A, B**](#f3){ref-type="fig"}, [**Table 1**](#T1){ref-type="table"}). In BR signaling, BRs activated and stabilized the two key transcription factors, BZR1 and BES1, to promote cell elongation through transcriptional activation of their target genes involved in cell elongation, including *PER1*, *IAA19*, *SAUR*s, and *EXPA8* ([@B51]; [@B62]; [@B6]; [@B57], [@B41]). Therefore, it is easy to understand that constitutive active forms of mutants *bzr1-1D* and *bes1-D* showed insensitivity to BRZ as well as a high dose of melatonin ([**Figures 4A--D**](#f4){ref-type="fig"}). Through a comparative expression analysis, we further confirmed that melatonin represses BR signaling in regulating hypocotyl elongation ([**Figures 4F--H**](#f4){ref-type="fig"} and [**5D--F**](#f5){ref-type="fig"} and [**Supplementary Figure S3**](#SM1){ref-type="supplementary-material"}).

We also observed that an inhibitory effect on hypocotyl of melatonin was eliminated by exogenous BL ([**Figures 5A--C**](#f5){ref-type="fig"}, [**Supplementary Figure S2**](#SM1){ref-type="supplementary-material"}), implying that melatonin functions in BR biosynthesis, because an exogenous application of BL could recover hypocotyl elongation of a BR-deﬁcient phenotype of BR synthesis mutants (*det2*, *cpd*, *dwarf4*, etc.), but not to BR receptor mutants (*bri1-5*) or other mutants (*bin2-1*) involved in BR signal transduction ([@B58]; [@B9]). In the present study, we also observed that even in the presence of high concentrations of melatonin, BL reversed hypocotyl inhibition of WT and *det2-1* mutant seedlings, but not *bri1-5* or *bin2-1* mutants ([**Figures 6A--C**](#f6){ref-type="fig"}). These observations further confirmed that melatonin suppresses BR biosynthesis in the regulation of hypocotyl elongation. In addition, the results of quantification of bioactive BR contents under treatment with melatonin also supported our conclusions ([**Figures 7A--C**](#f7){ref-type="fig"}). On the other hand, the recent investigations reported that rice seedlings with melatonin deficiency by knockdown of the enzyme gene required for melatonin biosynthesis showed a semi-dwarf phenotype and reduction of *DWARF4* transcripts and reduction of endogenous BR levels ([@B24]; [@B32]), suggesting that the lack of melatonin synthesis is likely related to BR suppression. In the present study, contradicting results were obtained likely due to the difference in species, because of no BR-deficient phenotype; for example, a de-etiolated phenotype in the dark condition and a short hypocotyl in the light condition were observed in melatonin biosynthesis-deficient mutants such as *snat1* ([@B32]).

BRs and GAs are two primary hormones regulating plant cell elongation/expansion; additionally, auxin also plays an important role in regulating cell elongation ([@B10]; [@B6]). It has been reported that melatonin upregulated GA biosynthesis genes such as *GA20ox* and *GA3ox* in cucumber seedlings in response to saline stress and resulted in a high level of active GAs such as GA3 and GA4 in the salt-inhibited germination process ([@B63]; [@B64]). Recently, melatonin was reported to negatively regulate auxin biosynthesis and the auxin response in *Arabidopsis* ([@B56]). Together, the above findings imply that melatonin inhibited hypocotyl elongation likely involved in the regulation of GA or auxin signaling. The expression profile analysis also showed a certain amount of auxin response genes, such as *SAUR*s and *IAAs*, in which some are co-regulated by BRs and auxin, involved in the regulation of cell elongation ([**Table 1**](#T1){ref-type="table"}). However, our results showed that just BL, but not IAA or GA~3~, could save the hypocotyl elongation ([**Supplementary Figure S2**](#SM1){ref-type="supplementary-material"}), suggesting that BRs, not auxin and GAs, play a predominant role in mediating the inhibition of hypocotyl elongation caused by a high concentration of melatonin.

Based on our results, we propose that melatonin decreases endogenous BR content through repressing BR biosynthesis, which leads to inactivation of BR signaling and reduction of transcriptional activity of BZR1/BES1 and then downregulation of the expression of BR-induced genes (*PRE1*, *IAA19*, *EXPA8* and *SAUR*s) involved in hypocotyl cell elongation and upregulation of the expression of BR-biosynthetic genes (*DAWF4*, *CPD*, *CYP90D1*, and *BR6OX2*) by negative feedback regulation. In summary, our findings reveal that melatonin inhibits hypocotyl elongation through repression of the BR biosynthesis in *Arabidopsis*; however, the mechanism of action needs further study to investigate how melatonin acts in the biosynthesis of BRs.
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